JNJ logo
JNJ@NYSE
Johnson & Johnson
$ 261.44+4.96 (+1.93%)
Buy JNJ
OpenPrice at market open
—
LowLowest price today
—
52-Week HighHighest past 52 weeks
—
HighHighest price today
—
52-Week LowLowest past 52 weeks
—
Market Cap.Total company value
618.09B
Today’s VolumeShares traded today
6.05M
Avg. VolumeAverage shares traded
7.5M
P/E RatioPrice to earnings ratio
29.65

Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

IPO Date
1962-01-02
Headquarters
New Brunswick, US
CEO
Joaquin Duato
Sector
Healthcare
Industry
Drug Manufacturers - General

Financial Statements

Earnings

Related Companies

ABBV logo
ABBVAbbVie Inc.
276.47
AMGN logo
AMGNAmgen Inc.
414.87
AZN logo
AZNAstraZeneca PLC
159.20
BMY logo
BMYBristol-Myers Squibb Company
59.12

Unlok the Future of Trading

Seamless access to global markets with AI-powered insights for smarter, more confident trading.

Device mockup